Earnings consistently backed by cash
Operating cash flow has matched or exceeded reported profit in 5 of the last 6 profit-making years (latest 1.38×).
Importance 49 / 95 · cash quality
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Operating cash flow has matched or exceeded reported profit in 5 of the last 6 profit-making years (latest 1.38×).
Importance 49 / 95 · cash quality
Free cash flow has been positive in 5 of the last 5 years.
Importance 44 / 95 · cash quality
Revenue has compounded at 6.4% a year over 7 years (₹8,533 → ₹13,193) — steady rather than rapid.
Importance 28 / 95 · growth
Classified by the exchange under Fast Moving Consumer Goods › Fast Moving Consumer Goods › Personal Products › Personal Care.
Peer set used on this page: 3 personal care.
Revenue has compounded at 6.4% a year over 7 years (₹8,533 → ₹13,193) — steady rather than rapid.
Rule REVENUE_COMPOUNDED_MODERATE
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q1 FY27 net profit was ₹586 cr, up 15.3% from ₹508 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q1 FY27 revenue was ₹3,764 cr, up 10.6% from ₹3,405 cr in Q1 FY26 a year earlier.
Rule QTR_REVENUE_GROWTH_YOY
Q1 FY27 net profit of ₹586 cr is the highest of the 16 quarters on record for this company.
Rule QTR_PROFIT_AT_RECORD
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Q2 FY25 | 3,029 | — | 418 | — | 13.8% |
| Q3 FY25 | 3,355 | +3.1% | 516 | +1.9% | 15.4% |
| Q4 FY25 | 2,830 | +0.6% | 313 | −8.3% | 11.0% |
| Q1 FY26 | 3,405 | +1.7% | 508 | +2.8% | 14.9% |
| Q2 FY26 | 3,191 | +5.4% | 445 | +6.5% | 13.9% |
| Q3 FY26 | 3,559 | +6.1% | 554 | +7.3% | 15.6% |
| Q4 FY26 | 3,038 | +7.3% | 362 | +15.8% | 11.9% |
| Q1 FY27 | 3,764 | +10.6% | 586 | +15.3% | 15.6% |
Trailing twelve months to 30 Jun 2026 · sum of the last 4 contiguous quarters
Margin and return trends are shown above.
Operating cash flow has matched or exceeded reported profit in 5 of the last 6 profit-making years (latest 1.38×).
Rule CFO_CONSISTENTLY_EXCEEDS_PAT
Free cash flow has been positive in 5 of the last 5 years.
Ranked against 3 personal care (FY2026, consolidated). No peer-relative rule fired for this company.
DABUR · 2nd of 3 · set median 5.0%
DABUR · 2nd of 3 · set median 23.1%
DABUR · 2nd of 3 · set median 16.2%
DABUR · 1st of 3 · set median 35.0×
On the trailing twelve months. Last full year: P/E 35.8× · P/S 4.8× · ROE 16.2%.
Long-term price performance is shown above.
Price-action indicators as of 2026-10-01. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 8,533 | 8,704 | 9,562 | 10,889 | 11,530 | 12,404 | 12,563 | 13,193 |
| Total income | 8,829 | 9,009 | 9,887 | 11,282 | 11,975 | 12,886 | 13,113 | 13,792 |
| EBITDA | 2,036 | 2,098 | 2,328 | 2,647 | 2,610 | 2,883 | 2,866 | 3,052 |
| Profit before tax | 1,875 | 1,728 | 2,057 | 2,270 | 2,220 | 2,359 | 2,257 | 2,422 |
| Net profit | 1,597 | 1,448 | 1,695 | 1,742 | 1,701 | 1,811 | 1,740 | 1,869 |
| EPS (₹) | 8.2 | 8.2 | 9.6 | 9.8 | 9.6 | 10.4 | 10.0 | 10.7 |
| Net worth | 5,663 | 6,642 | 7,700 | 8,422 | 9,441 | 10,303 | 11,210 | 11,803 |
| Total debt | 524 | 467 | 483 | 1,007 | 999 | 1,158 | 730 | 1,063 |
| Operating cash flow | — | — | 2,057 | 1,802 | 1,488 | 2,013 | 1,987 | 2,579 |
| Free cash flow | — | — | — | 1,433 | 1,003 | 1,453 | 1,448 | 2,180 |
| Ratio | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Growth | ||||||||
| Revenue growth YoY | — | 2.0 | 9.9 | 13.9 | 5.9 | 7.6 | 1.3 | 5.0 |
| Profit growth YoY | — | -9.3 | 17.1 | 2.8 | -2.4 | 6.5 | -3.9 | 7.4 |
| Profitability | ||||||||
| EBITDA margin % | 23.9 | 24.1 | 24.3 | 24.3 | 22.6 | 23.2 | 22.8 | 23.1 |
| Net margin % | 18.1 | 16.1 | 17.1 | 15.4 | 14.2 | 14.1 | 13.3 | 13.5 |
| Return on equity % | 28.2 | 23.5 | 23.6 | 21.6 | 19.0 | 18.3 | 16.2 | 16.2 |
| Return on capital % | 30.0 | 28.2 | 27.3 | 27.2 | 23.1 | 22.7 | 20.7 | 20.8 |
| Leverage & cash | ||||||||
| Debt to equity | 0.09 | 0.07 | 0.06 | 0.12 | 0.11 | 0.11 | 0.07 | 0.09 |
| Cash flow ÷ profit | — | — | 1.21 | 1.03 | 0.87 | 1.11 | 1.14 | 1.38 |
| Current ratio | 1.35 | 1.98 | 1.63 | 1.30 | 1.18 | 1.45 | 1.51 | 1.70 |